Showing results (21-30 of 396) with videos related to
Sort By:
Pageof 40
Journal of Medicinal Chemistry|February 1, 1987
The mechanism of activation of 4-hydroxycyclophosphamideR F Borch, J A MillardJournal of Leukocyte Biology|April 1, 1987
Low-dose X-irradiation and 4-hydroperoxycyclophosphamide distinguishes three Lyt-1+ lymph node T-cell subtypes that respond to specific antigen in vitroC Clark, I LaSota, R F BorchJournal of Medicinal Chemistry|November 7, 2000
Activation mechanisms of nucleoside phosphoramidate prodrugsC L Freel Meyers, R F BorchJournal of Leukocyte Biology|February 1, 1985
Evidence that X-irradiation and 4-hydroperoxycyclophosphamide affects different lymphocytes that respond to specific antigen in vitroC Clark, I LaSota, R F BorchJournal of Medicinal Chemistry|August 24, 2000
Development of novel quinone phosphorodiamidate prodrugs targeted to DT-diaphoraseC Flader, J Liu, R F BorchSeminars in Oncology|August 1, 1989
Intraperitoneal cisplatin chemotherapy in the management of ovarian carcinomaM MarkmanCancer Investigation|January 1, 1987
Clinical cancer research, DNR orders, and medical economics: a complex interrelationshipM MarkmanThe American Journal of the Medical Sciences|March 1, 1986
Cytotoxic intracavitary chemotherapyM MarkmanAnnals of Medicine|August 1, 1996
Intraperitoneal chemotherapy in the treatment of ovarian cancerM MarkmanAnnals of Oncology : Official Journal of the European Society for Medical Oncology|December 20, 2011
The use of bevacizumab in the management of ovarian cancer: an argument for single-agent rather than combination therapyM MarkmanPageof 40